| 摘要 |
PROBLEM TO BE SOLVED: To provide a formulation that makes it possible to utilize Muse cells in a more practical form.SOLUTION: The present invention provides a formulation administered to an uninjured site for the treatment of myocardial injury, comprising a compound that activates sphingosine-1-phosphoric acid receptor 2(S1PR2) as an active ingredient.SELECTED DRAWING: None |
